Nikhil Mukhi

1.1k total citations
14 papers, 891 citations indexed

About

Nikhil Mukhi is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Nikhil Mukhi has authored 14 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Nikhil Mukhi's work include Venous Thromboembolism Diagnosis and Management (3 papers), T-cell and Retrovirus Studies (2 papers) and Cancer Mechanisms and Therapy (2 papers). Nikhil Mukhi is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (3 papers), T-cell and Retrovirus Studies (2 papers) and Cancer Mechanisms and Therapy (2 papers). Nikhil Mukhi collaborates with scholars based in United States and China. Nikhil Mukhi's co-authors include Delong Liu, Akintunde Akinleye, Muhammad Furqan, Yamei Chen, Yongping Song, Byung Moo Lee, Shundong Cang, Kemeng Wang, Varun Mittal and Byung Cheol Lee and has published in prestigious journals such as Blood, Journal of Hematology & Oncology and Journal of Investigative Medicine.

In The Last Decade

Nikhil Mukhi

13 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nikhil Mukhi United States 7 398 367 283 250 159 14 891
Paweł Robak Poland 19 539 1.4× 372 1.0× 269 1.0× 343 1.4× 186 1.2× 86 1.1k
Simon He Australia 9 470 1.2× 245 0.7× 151 0.5× 251 1.0× 209 1.3× 14 846
Ningshu Liu Germany 11 561 1.4× 275 0.7× 224 0.8× 225 0.9× 340 2.1× 30 1.1k
Beth Fischer United States 9 298 0.7× 328 0.9× 309 1.1× 426 1.7× 161 1.0× 28 829
Michele S. Redell United States 18 562 1.4× 402 1.1× 100 0.4× 117 0.5× 203 1.3× 50 1.1k
Carmela Gurrieri Italy 18 915 2.3× 393 1.1× 196 0.7× 304 1.2× 353 2.2× 46 1.5k
Elisabetta Calabrese Italy 13 508 1.3× 399 1.1× 131 0.5× 186 0.7× 185 1.2× 37 1.0k
Patricia Gomez‐Bougie France 22 1.0k 2.6× 395 1.1× 182 0.6× 146 0.6× 201 1.3× 38 1.3k
Ricardo Parrondo United States 15 374 0.9× 255 0.7× 102 0.4× 130 0.5× 86 0.5× 75 698

Countries citing papers authored by Nikhil Mukhi

Since Specialization
Citations

This map shows the geographic impact of Nikhil Mukhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikhil Mukhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikhil Mukhi more than expected).

Fields of papers citing papers by Nikhil Mukhi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikhil Mukhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikhil Mukhi. The network helps show where Nikhil Mukhi may publish in the future.

Co-authorship network of co-authors of Nikhil Mukhi

This figure shows the co-authorship network connecting the top 25 collaborators of Nikhil Mukhi. A scholar is included among the top collaborators of Nikhil Mukhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikhil Mukhi. Nikhil Mukhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Mukhi, Nikhil, et al.. (2022). Transient Sideroblastic Anemia Post-COVID-19 Infection. Cureus. 14(10). e30275–e30275. 2 indexed citations
2.
Mukhi, Nikhil, et al.. (2016). Role of Histone Deactylase (Hdac) Inhibitors in adult T-Cell Lymphoma/Leukemia (Atl). Journal of Investigative Medicine. 64(3). 805–805. 1 indexed citations
3.
Mukhi, Nikhil, et al.. (2015). Chalazia Development in Multiple Myeloma: A New Complication Associated with Bortezomib Therapy. Hematology Reports. 7(2). 5729–5729. 7 indexed citations
4.
Mukhi, Nikhil, et al.. (2015). Romidepsin in Relapsed/Refractory HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia: A Case Series. Blood. 126(23). 5113–5113. 4 indexed citations
5.
Nabors, Christopher, Sahil Khera, Dhaval Kolte, et al.. (2014). Improving Resident Morning Sign-Out by Use of Daily Events Reports. Journal of Patient Safety. 11(1). 36–41. 2 indexed citations
6.
Mukhi, Nikhil, et al.. (2014). HIT: Secondary Drop Phenomenon in Platelets. Blood. 124(21). 4198–4198.
7.
Mukhi, Nikhil, et al.. (2014). Thromboprophylaxis use in medical inpatients and the impact of electronic risk assessment tool. Blood. 124(21). 3511–3511. 1 indexed citations
8.
Furqan, Muhammad, et al.. (2014). The Conundrum of “Warfarin Hypersensitivity”. American Journal of Therapeutics. 23(3). e911–e915. 4 indexed citations
9.
Akinleye, Akintunde, et al.. (2013). MEK and the inhibitors: from bench to bedside. Journal of Hematology & Oncology. 6(1). 27–27. 236 indexed citations
10.
Furqan, Muhammad, Akintunde Akinleye, Nikhil Mukhi, et al.. (2013). STAT inhibitors for cancer therapy. Journal of Hematology & Oncology. 6(1). 90–90. 154 indexed citations
11.
Akinleye, Akintunde, Yamei Chen, Nikhil Mukhi, Yongping Song, & Delong Liu. (2013). Ibrutinib and novel BTK inhibitors in clinical development. Journal of Hematology & Oncology. 6(1). 59–59. 186 indexed citations
12.
Furqan, Muhammad, Nikhil Mukhi, Byung Moo Lee, & Delong Liu. (2013). Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application. Biomarker Research. 1(1). 5–5. 145 indexed citations
13.
Cang, Shundong, Nikhil Mukhi, Kemeng Wang, & Delong Liu. (2012). Novel CD20 monoclonal antibodies for lymphoma therapy. Journal of Hematology & Oncology. 5(1). 64–64. 108 indexed citations
14.
Lee, Byung Cheol, Nikhil Mukhi, & Delong Liu. (2012). Current management and novel agents for malignant melanoma. Journal of Hematology & Oncology. 5(1). 3–3. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026